MarketPeel
Insider Trading Intelligence
Pricing
…
JW

James Dean Watson

SCTX
DIRECTOR · SCRIBE THERAPEUTICS, INC. · CIK 0002130384
FILING MIX · LIFETIME100%/0%
BUYS
1
SELLS
0
TOTAL VALUE
$0
COMPANIES
1
ACTIVE SINCE
Jul 2026
HOLDINGS NOW
14,725
AVG SELL PX
—
TRADE KIND
SHOWING 1 / 1
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
No backtest data available for James Dean Watson. Backtests are computed for purchase (P) and sale (S) transactions with resolvable price history.
Holdings over time
Not enough transaction history to chart holdings.
Trading cadence · quarterly flow
BUY ● SELL ●
2026
FLOW · 1 buys / 0 sellsCOVERAGE · 1 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
SCTX
SCRIBE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
14,725——14,725Jul 23, 2026Jul 27, 2026 ↗View →
Other insiders · SCTX
Loading peer insiders…
About this filer
CIK 0002130384
ROLE
Director
PRIMARY
SCTX
COMPANIES
1
ACTIVE SINCE
Jul 2026
MARKETPEEL · /INSIDER/0002130384DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback